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ABSTRACT
PPAR2 is a critical lineage-determining transcrip-
tion factor that is essential for adipogenic differ-
entiation. Here we report characterization of the
three-dimensional structure of the PPAR2 locus
after the onset of adipogenic differentiation and
the mechanisms by which it forms. We identified a
differentiation-dependent loop between the PPAR2
promoter and an enhancer sequence 10 kb upstream
that forms at the onset of PPAR2 expression. The
arginine methyltransferase Prmt5 was required for
loop formation, and overexpression of Prmt5 re-
sulted in premature loop formation and earlier onset
of PPAR2 expression. Kinetic studies of regulatory
factor interactions at the PPAR2 promoter and en-
hancer revealed enhanced interaction of Prmt5 with
the promoter that preceded stable association of
Prmt5 with enhancer sequences. Prmt5 knockdown
prevented binding of both MED1, a subunit of Me-
diator complex that facilitates enhancer–promoter
interactions, and Brg1, the ATPase of the mam-
malian SWI/SNF chromatin remodeling enzyme re-
quired for PPAR2 activation and adipogenic differ-
entiation. The data indicate a dynamic association of
Prmt5 with the regulatory sequences of the PPAR2
gene that facilitates differentiation-dependent, three-
dimensional organization of the locus. In addition,
other differentiation-specific, long-range chromatin
interactions showed Prmt5-dependence, indicating a
more general role for Prmt5 in mediating higher-order
chromatin connections in differentiating adipocytes.
INTRODUCTION
In addition to being a primary storage site for excess fat, adi-
pose tissue is an active endocrine organ that producesmulti-
ple secreted factors such as adipokines that influence signal-
ing, metabolism and the immune system. Obesity changes
the generation and release of adipokines such that obese
adipose tissue produces inflammatory cytokines involved in
the initiation and development of metabolic syndromes in-
cluding insulin resistance, diabetes and cardiovascular dis-
eases (1). Many molecular mechanisms have been identi-
fied in adipocyte differentiation using in vitro adipocyte
models. The developmental process from adipocyte precur-
sors (pre-adipocytes) to adipocytes is controlled by an array
of transcription factors, most notably the master regulator
peroxisome proliferator-activated receptor 2 (PPAR2)
that directs adipocyte gene expression in conjunction with
CCAAT/enhancer-binding protein- (C/EBP)(2). Prior
to the induction of these critical lineage determining fac-
tors, the early transcription factor C/EBPmarks hotspots
where multiple factors converge in the same genomic re-
gion in a stretch of ∼400 bp on adipogenic genes, leading
to changes in epigenetic marks and alterations in chromatin
structure (3,4).
Such hotspots are not restricted to the promoters of adi-
pogenic genes. Indeed, they can be observed at more dis-
tal regions. These enhancer sequences have been proposed
to act through DNA looping (5–7) to bring these elements
closer to the promoters to influence adipogenic gene ex-
pression. One such potential enhancer is located 10 kb
upstream relative to the transcription start site (TSS) of
PPAR2. First identified as a region that showed dynamic
changes in H3K9 acetylation and C/EBP binding (8), this
sequence has also been established as having increased levels
of DNAse hypersensitivity (9), H3K27 acetylation, H3K4
mono and di-methylation, and Pol II binding as a function
of adipogenesis (10). With respect to transcription factor
binding, multiple transcription factors, including C/EBP,
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C/EBP, MLL4, KLFs and STATs, converge on this ele-
ment early upon induction of adipogenesis (11).
While extensive research has examined the role of lysine
modifications with respect to the control of gene expression
in adipogenesis, the impact of arginine post-translational
writers is less well characterized. Protein arginine methyl-
transferase 5 (Prmt5) is an arginine methyltransferase that
symmetrically di-methylates arginine residues on histone
H2AR3 (12) as well as H4R3 (13) and H3R8 (14). In ad-
dition, it methylates non-histone proteins involved in RNA
processing, DNA damage, cell cycle regulation and cancer
(15). Prmt5 has been shown to be required for both myoge-
nesis (16,17) and adipogenesis (18). Our prior work showed
that it is necessary for the expression of late adipocyte-
specific genes because it facilitates binding of adenosine
triphosphate (ATP)-dependent chromatin remodeling en-
zymes and for the auto-regulatory process driving the ex-
pression of PPAR2. At the end point of differentiation,
Prmt5 binds to the−10 kb region of the PPAR2 locus and,
when overexpressed, facilitates earlier adipogenic differen-
tiation (18). However, the exact mechanism by which Prmt5
drives adipogenesis, in particular with respect to PPAR2
induction, is unknown.
Our current study shows that Prmt5 is necessary for
a differentiation-dependent DNA looping interaction be-
tween the PPAR2 promoter and the −10 kb region. As
a function of differentiation, binding of Prmt5 transitions
from binding at the PPAR2 promoter to the upstream en-
hancer. This transition occurs prior to the formation of the
loop, and the onset of looping tracks with PPAR2 expres-
sion. Prmt5 was required for the recruitment of MED1 and
Brg1 to both the PPAR2 promoter as well as the −10 kb
enhancer. Overexpression of Prmt5 facilitated earlier bind-
ing of MED1 to the promoter and PPAR2 expression
was induced earlier and to a greater extent. Taken together
these findings suggest a novel role for Prmt5 in adipogenesis
in facilitating an enhancer–promoter loop to promote ex-
pression of a lineage-determining transcription factor and
subsequent adipogenic differentiation. Additional findings
indicate that Prmt5 is also required for the formation of
other long-range, differentiation-dependent chromatin in-
teractions, suggesting amore general role for Prmt5 in high-
order chromatin organization.
MATERIALS AND METHODS
Chromosome conformation capture (3C)
The 3C assay was adapted from published methods with re-
visions (19–21). C3H10T1/2 plates were cross-linked in 1%
formaldehyde for 5 min and quenched in 0.125 M glycine.
Samples were pelleted and resuspended with lysis buffer
(10 mM Tris HCI pH 8.0, 10 mM NaCl, 0.5% NP-40
and protease inhibitor cocktail (Sigma-Aldrich, St Louis,
MO, USA), homogenized by douncing, and washed and
resuspended in 1 ml of NEB buffer CutSmart. Ten 100-l
aliquots were taken. A total of 262 l of Cutsmart buffer
was added to each, followed by 38 l of 1% sodium do-
decyl sulphate (SDS) and samples were heated for 10 min
at 65◦C. SDS was then quenched by addition of 44 l of
10% Triton X-100. Each aliquot of lysate was digested with
400 units of restriction enzymes StuI and PvuII and incu-
bated overnight at 37◦C. The restriction enzymes were inac-
tivated by addition of 10% SDS to a final concentration of
1.6% (86 l) for 30 min at 65◦C. The digested samples were
then treated with a ligation cocktail containing 745 l of
10% Triton X-100, 745 l of 10× ligation buffer (500 mM
Tris–HCl pH7.5, 100 mM MgCl2 and 100 mM DTT), 80
l of 10 mg/ml bovine serum albumin, 80 l of 100 mM
ATP and water to bring the total volume to 7.6 ml. Each
aliquot was then ligated with 5000 U of T4 DNA ligase for
4 h at 16◦C. Cross-linked DNA was reversed by proteinase
K (20 mg/ml) and RNase A (10 mg/ml) overnight. All lig-
ated samples for each sample were then pooled and puri-
fied with either a phenol/chloroform extraction followed by
ethanol precipitation or with the DNeasy Blood and Tis-
sue kit (Qiagen). Purified DNA samples were analyzed by
realtime polymerase chain reaction (PCR) using a standard
curve on theABI StepOne Plus (Applied Biosystems, Foster
City, CA, USA) and interaction frequencies were normal-
ized to the values of intra-genic interactions occurring at the
endogenous TFIIH (ERCC3) locus (22). The interaction
frequency was calculated as the ratio of ligated products
to the corresponding frequency of random ligation of the
product from the digested bacterial artificial chromosome
(BAC) encoding the mouse PPAR locus (RP24–163B22)
as described (23). Primers for 3C experiments are listed in
Supplemental Table S1 or were published previously (23).
Cell culture
Proliferating C3H10T1/2 mesenchymal stem cells and 3T3-
L1 cells were maintained in 10% fetal calf serum (FCS).
For adipogenic differentiation, 2 day post-confluent cells
were differentiated using a standard adipogenic cocktail
(1 g/ml insulin, 0.25 g/ml dexamethasone, 0.5 mM
IBMX, with 10% FCS). The cocktail for differentiating
C3H10T1/2 cells also included 10 M troglitazone. After
48 h, cells were maintained in medium containing 1 g/ml
insulin until harvest. Retroviruses encoding Prmt5 or anti-
sense Prmt5 (14,24) were generated in Bosc23 cells (25).
siRNA
Prior to transfection, cells were grown in antibiotic free
medium. Cells were transfected at 60–70% confluence us-
ing the Lipofectamine 2000 (Invitrogen) reagent with 40 nM
siRNA (scrambled, MED1 or Prmt5) for 6 h with replace-
ment of growth media. C/EBP knockdown was accom-
plished with Mm Cebpa 1 FlexiTube siRNA or Mm Cebpa
2 FlexiTube siRNA (Qiagen) under the same conditions.
Forty-eight hours after transfection, the cells were induced
to differentiate. The cells were harvested for chromatin im-
munoprecipitation (ChIP), protein and Oil Red O staining
at the indicated time points. siRNA sequences are listed in
Supplemental Table S1.
Oil Red O staining
The differentiating cells were fixed with 10% phosphate-
buffered formalin for 1 h. The cells were washed with phos-
phate buffered saline (PBS) and 60% isopropanol twice. The
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cells were then stained with a working solution of 60% Oil
Red O (60:40 stain-water) for 1 h and washed repeatedly
with water to remove excess Oil Red O.
Reporter assays
A fragment containing the −10 kb region was amplified
from mouse genomic DNA and inserted into the KpnI
site of a pGL3-basic luciferase plasmid (Promega, Madi-
son, WI, USA) that contains 1.6 kb of the promoter for
PPAR2. Plasmids were screened for orientation and veri-
fied by restriction digest and sequencing by GeneWiz. Lu-
ciferase assays were performed using the Dual-Glo Lu-
ciferase Assay System (Promega) on the Glo/Max lumi-
nometer. Primer sequences are listed in Supplemental Table
S1.
RNA isolation and analysis
RNA was purified using the TRIzol reagent (Invitro-
gen), and quantitative reverse transcription-PCR was per-
formed as described previously (18). The relative amounts
of PPAR2 were determined using the comparative thresh-
old cycle method (26) and normalized to the relative levels
of cyclophilin BmRNA. Primer sequences are listed in Sup-
plemental Table S1.
Chromatin immunoprecipitation (ChIP) and Re-ChIP assays
ChIP assays on samples harvested from C3H10T1/2 cells
under the listed conditions at the specified time points were
performed as described previously (18). Samples were cross-
linked in 1% formaldehyde and quenched with 0.125 M
glycine. Sample were then lysed in a buffer [1% sodium
dodecyl sulfate (SDS), 10 mM ethylenediaminetetraacetic
acid (EDTA), 50 mM Tris–HCl (pH 8.1)] containing pro-
tease inhibitors (Roche eComplete tablet) and sonicated in
a Bio-Ruptor (Diagenode) to 500 bp. A total of 100 g
of sonicated lysates were diluted in immunoprecipitation
dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, 16.7 mM Tris (pH 8.1), 167 mM NaCl] containing
protease inhibitors (Sigma-Aldrich, St Louis, MO, USA).
Antibodies were then added to lysates and the combined
antibody/DNA complexes were incubated with Magna-
ChIP A/G beads (EMD Millipore) overnight at 4◦. Beads
were washed in low salt [0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris–HCl (pH 8.1), 150 mM NaCl], once in
high salt buffer (same buffer containing 500 mM NaCl),
followed by LiCl buffer [0.25 M LiCl, 1% Nonidet P-40,
1% sodium deoxycholate, 1 mM EDTA, 10 mM Tris–HCl
(pH 8.1)] and finally were washed with Tris–EDTA (pH
8.0). Complexes were released from the beads using elu-
tion buffer [1% SDS 0.1M NaHCO3 with Proteinase K for
2 h while shaking at 62◦C. The samples were purified with
the Zymo ChIP purification kit (Zymo). Either polyclonal
rabbit antisera against Prmt5 (24) and Brg1 (27) and puri-
fied antibodies against MED1 (Bethyl Labs, Montgomery,
TX, USA) or normal rabbit IgG (Millipore Corp., Bedford,
MA,USA)were used. PurifiedDNAwas analyzed by quan-
titative real-time PCR. Primer sequences are listed in Sup-
plemental Table S1.
For re-ChIP, after washing as described above, the im-
mune complexes were eluted in 50 l for 10 min at room
temperature, and this was repeated twice to obtain 150l in
total. A total of 75 l of this eluate was decrosslinked, pu-
rified and analyzed by quantitative real-time PCR directly
(first round ChIP only), and the remaining 75 l was di-
luted to a final volume of 750 l using ChIP dilution buffer
without SDS. After addition of the second-round ChIP an-
tibody, the samples were incubated overnight at 4◦C and
treated as described above. Elution was performed as de-
scribed for the first-round re-ChIP and the eluate was de-
crosslinked, purified and analyzed by quantitative real-time
PCR.
Protein analysis
Day 0 and day 6C3H10T1/2 10-cm plates were scraped into
1 ml of PBS. The cell pellets were snap frozen in liquid N2
and stored at −80 C. The pellets were resuspended in 200
l of lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150
mMNaCl, 0.5%Nonidet P-40 and 20% glycerol, along with
Sigma protease inhibitor cocktail. After sonication, the pro-
tein amounts were quantified using a Bradford assay. Pro-
tein (50 g) was loaded on an sodium dodecyl sulphate-
polyacrylamide gel electrophoresis gel and transferred to a
nitrocellulose membrane. Primary antibodies were Prmt5
(Santa Cruz; sc-22132), GAPDH (Sigma G9295), MED1
(Bethyl A300–793), C/EBP (Santa Cruz, sc-9314) and p85
phosphatidylinositol-3-kinase (PI3K; Millipore ABS234).
Bands were detected by secondary conjugated horseradish
peroxidase antibodies and enhanced chemiluminescence
detection.
RESULTS
C/EBP activates the −10 kb enhancer upstream of the
PPAR2 promoter
In addition to the histone modifiers, transcriptional regu-
lators and DNAse hypersensitivity at the −10 kb enhancer
(8–10), it has been shown to be bound by C/EBP in dif-
ferentiated adipocytes and activates a reporter in response
to differentiation of 3T3-L1 cells (8). Cycling C3H10T1/2
cells were transfected with a luciferase reporter construct
containing a fragment of the−10-kb upstream region fused
to 1.6 kb of the PPAR2 promoter in the presence of in-
creasing amounts of C/EBP plasmid. At the maximal ac-
tivation amount of 100 ng, C/EBP activated the promoter
construct 4-fold and activated the promoter and enhancer
construct 14-fold (Supplemental Figure S1). C/EBP lev-
els produced at 200 and 400 ng of transfected plasmid ex-
hibited reductions in activation (Supplemental Figure S1),
likely due to squelching (28). These results serve as a cor-
roboration of the enhancer properties of the −10 kb region
with respect to C/EBP-mediated activation.
Adipogenic differentiation alters the chromatin landscape at
the PPAR2 locus
Although enhancers for genes may be distant to the genes
they influence, much research has focused on the DNA
looping between promoters and enhancers to target the
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Figure 1. 3C analysis of regions 80 kb upstream and downstream of the
PPAR2 TSS. (A) 3C analysis of the PPAR locus in day 0 and day 4 dif-
ferentiated C3H10T1/2 cells. The positions of the PPAR1 and PPAR2
genes are diagramed relative to the x-axis, which indicates the genomic po-
sition relative to the PPAR2 TSS. The anchor position at the PPAR2
promoter is indicated. The interaction frequency was normalized to the
value between the promoter and the −10 kb region in day 0 undifferenti-
ated cells; this −10 kb value was set at 0 to show changes in Ct values
relative to the −10 kb interaction. (B) Relative 3C values from (A) shown
to reflect the differences between the differentiated and undifferentiated
states. (C) Time course of interaction frequency between the promoter and
the −10 kb enhancer sequence. Samples of C3H10T1/2 cells were taken at
the 0 h timepoint and at 3, 6, 12, 24 and 96 h following differentiation. All
results are from three independent samples performed in triplicate. Error
bars: Mean + SD (*P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two
tailed t-test).
transcriptional apparatus to the region around the start site
of transcription (29). While previous studies have exam-
ined looping in adipogenesis, thus far they have been re-
stricted to brown fat (30,31) or have focused on the loci
encoding uncoupling proteins 2 and 3 (32). We performed
chromosome conformation capture (3C) assays (33) to ex-
amine the PPAR locus. Setting the PPAR2 promoter as
an anchor point, we investigated the interactions between
the promoter and different regions of the locus using frag-
ments generated by PvuII and StuI, which generate cleav-
age fragments that include both the −10 kb enhancer and
the proximal promoter region. While the promoter exhib-
ited interactions with many regions of the PPAR2 locus in
both undifferentiated and differentiated cells (Figure 1A),
we noted a >40-fold differentiation-dependent change in
the association of the promoter and the upstream enhancer
(Figure 1B). We also observed a statistically significant in-
crease in association between the promoter and a region∼7
kb downstream of the PPAR2 TSS. This region encom-
passes a previously identified hotspot that includes a region
ofDNAse I hypersensitivity and binding of 15 transcription
factors associated with adipogenic activation at ∼ +3 kb
(11) and C/EBP, C/EBP and PPAR2 binding at +13
kb (8,9), however, this interaction was not further investi-
gated. Based on the evidence of a differentiation-dependent
change in interaction frequency between the −10 kb en-
hancer and the PPAR2 promoter, we examined the kinet-
ics of loop formation. The increase in loop formation oc-
curred at the 12 h time point and the loop persisted through-
out differentiation (Figure 1C). We also confirmed the ex-
istence of a PPAR2 promoter–enhancer loop in differen-
tiating 3T3-L1 cells, a different cell model for adipogenesis.
In the 3T3-L1 model, the loop appeared earlier, suggesting
minor differences in the kinetics of loop formation in the
two different cell lines (Supplemental Figure S2A). These
findings show reorganization of the higher order chromatin
structure at the PPAR2 locus as a function of adipogenic
differentiation.
C/EBP contributes to formation of the loop at the PPAR2
locus
Since C/EBP binds to the −10 kb enhancer sequence (8)
and can activate it (Supplemental Figure S1), we tested
whether C/EBP contributed to loop formation. Knock-
down of C/EBP was achieved by siRNA treatment (Sup-
plemental Figure S3A and B). Assessment of loop forma-
tion at 12 h post-differentiation revealed that the frequency
of loop formation decreased by about 50% but was well
above the observed frequency at the onset of differentia-
tion (Supplemental Figure S3C).We conclude that C/EBP
contributes to loop formation but is not essential.
Prmt5 governs formation of the loop as well as its timing
Given our previous findings that Prmt5 is necessary for
adipogenesis (18), we investigated whether the DNA loop-
ing interactions are dependent on Prmt5. A time course
of Prmt5 protein expression in differentiating C3H10T1/2
cells was performed; levels were similar at each time point
examined (Figure 2A). C3H10T1/2 cells were then infected
with an empty retroviral vector, with a retroviral vector en-
coding a human Prmt5 antisense construct previously used
to generate stable fibroblast cell lines that exhibited reduced
levels of Prmt5 (14), or with a retroviral vector encoding
human Prmt5 to allow us to observe the effects of overex-
pression. Infected cells were selected by puromycin, grown
to confluence and differentiated. Western blot and Oil Red
O analysis verified the overexpression and knockdown (Fig-
ure 2B). Consistent with prior results (18), Prmt5 reduction
blocked adipogenic differentiation and Prmt5 overexpres-
sion accelerated differentiation (Figure 2C). Prmt5 reduc-
tion blocked the formation of the loop between the pro-
moter and the upstream enhancer of PPAR2 (Figure 2D).
These results were confirmed in 3T3-L1 cells inwhich Prmt5
levels were reduced (Supplemental Figure S2B–D), demon-
strating the generality of the finding. In contrast, cells over-
expressing Prmt5 showed increased interaction frequency at
6 h post-differentiation (Figure 2E), indicating that Prmt5
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Figure 2. Loop formation requires Prmt5. (A) Western blot time course of Prmt5 protein levels over the time course of C3H10T1/2 cells differentiation.
PI3K levels were monitored as a control. (B–E) C3H10T1/2 cells were infected with retroviruses containing either a control vector, wild-type Prmt5 or
antisense Prmt5. (B) Western blots showing levels of Prmt5 in cells expressing empty vector, antisense and overexpressed Prmt5 96 h post-differentiation.
GAPDH levels were monitored as a control. (C) Oil red O staining for cells 4 days post-differentiation. (D) Control vector and antisense Prmt5 expressing
cells either collected just prior to differentiation (0 h) or 96 h later were tested by 3C for interactions between the PPAR2 promoter and the −10 kb
enhancer. (E) Control or cells overexpressing Prmt5 were differentiated for the specified times. Relative interaction frequencies for the interaction between
the PPAR2 promoter and the −10 kb enhancer were set to the value at the 0 h time point. All results are from three independent samples performed in
triplicate. Error bars: Mean + SD (**P < 0.01, ***P < 0.001 by Student’s two tailed t-test).
levels regulate loop formation. There was a decrease in over-
all interaction frequency compared to uninfected cells (Fig-
ure 1), whichwas attributed to the retroviral infection. Thus,
Prmt5 is essential for the formation of the loop and overex-
pression of Prmt5 can facilitate earlier loop formation.
Transition of Prmt5 binding from the PPAR2 promoter to
the −10 kb enhancer precedes loop formation
To test whether Prmt5 binding plays a role in the formation
of the promoter–enhancer loop, we assessed the kinetics of
Prmt5 occupancy at the PPAR2 promoter or upstream en-
hancer usingChIP.We previously reportedminimal binding
for Prmt5 at the PPAR2 promoter but rather significant
binding at the upstream enhancer at the endpoint of differ-
entiation (18).
The kinetic analysis revealed enhanced Prmt5 occupancy
at the PPAR2 promoter at 6 h post-differentiation (Fig-
ure 3A). In contrast, binding of Prmt5 to the enhancer in-
creased gradually over the time course of differentiation
with maximal binding observed at the endpoint (Figure
3A). Overexpression of Prmt5 shifted its occupancy to 3 h
post-differentiation at the promoter and elevated binding at
the enhancer (Figure 3B), consistent with the earlier forma-
tion of the loop (Figure 2E). These results show dynamic
binding by Prmt5 at the PPAR2 locus prior to loop for-
mation.
Loop formation and changes in Prmt5 binding are associated
with the onset of PPAR2 expression
Given the formation of a loop between the upstream
enhancer and the promoter of PPAR2 along with the
dynamic binding patterns of Prmt5, we tested whether
PPAR2 expression was related to the differential binding
of Prmt5. Prmt5 knockdown was previously shown to pre-
vent upregulation of both PPAR2 and adipogenic differ-
entiation (18). Using RNA samples at 3 h intervals from 0
to 18 h, we observed that PPAR2 expression was induced
above background at the 12 h time point in cells containing
the control vector. A significant 2.7-fold increase in mRNA
expression was observed at 9 h post-differentiation in cells
overexpressing Prmt5 (Figure 3C). In both the control and
the cells overexpressing Prmt5, PPAR2 mRNA levels con-
tinued to increase at the later points as a function of differ-
entiation.
MED1 and Brg1 binding at the PPAR2 locus
In order to explore the mechanism by which Prmt5 could
influence loop formation, we considered two candidates
previously shown to be involved in regulating DNA loop-
ing, Brg1 and MED1. Brg1, an ATPase of the mammalian
SWI/SNF chromatin remodeling complex, has been shown
to be necessary for adipogenesis (34), interacts with Prmt5
(14,17) and is required for looping at the -globin and -
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Figure 3. Prmt5 binding at the PPAR2 enhancer versus the promoter.
(A) Samples were collected for ChIP from differentiated C3H10T1/2 cells
infected with a retrovirus containing the control vector. (B) Samples were
collected for ChIP from differentiated C3H10T1/2 cells infected with a
retrovirus for Prmt5 to generate Prmt5 overexpression. (C) Overexpres-
sion of Prmt5 resulted in precocious PPAR2 expression. RNA samples
were taken at the specified time points. The level of PPAR2 expression
in cells expressing the control empty vector at time 0 was set to 1. Exper-
iments from three independent samples were performed in triplicate and
significance is based on values relative to the 0 h time point. (*P < 0.05,
**P < 0.01, by Student’s two tailed t-test).
globin loci during hematopoiesis (35–37) contraction of the
IgH locus to establish B cell identity (38), and at the Th2
cytokine and CIITA loci (39,40). MED1, also known as
Trap220 or Drip205, is a subunit of the Mediator complex
that broadly contributes to transcriptional activation (41).
It is required for PPAR2 induced adipogenesis (42) and
has been shown to interact with PRDM16, the major regu-
lator of brown fat determination (30,31). Previous analyses
have documented the binding ofMED1 to the PPAR2 up-
stream enhancer as well as to the promoter (8,42) and other
work has implicated MED1 in DNA looping (43). Addi-
tionally, Prmt5 has been shown to interact with the CDK
domains of the Mediator complex (44). At the PPAR2
promoter, both Brg1 and MED1 displayed patterns of oc-
cupancy with initial binding at 6 h, maximal binding at 12
h and decreased binding as a function of differentiation
(Figure 4A). The enhanced binding of Brg1 and MED1
at the PPAR2 promoter early in the differentiation pro-
Figure 4. MED1 and Brg1 kinetics of binding at the PPAR2 locus. ChIP
assays for Brg1 and MED1 were performed on 10T1/2 cells differentiated
for the indicated times. DNA immunoprecipitated by antibodies against
Brg1 and MED1 was amplified and quantified by real-time PCR for the
(A) PPAR2 promoter or (B) the −10 kb enhancer. Data are presented as
fold enrichment over the amount of DNA amplified after immunoprecip-
itation by the control IgG. All results are from three independent samples
performed in triplicate with significance based on values relative to the 0 h
time point. Error bars: Mean + SD (*P < 0.05, **P < 0.01, ***P <0.001
by Student’s two tailed t-test).
cess mirrors that observed for Prmt5 (Figure 3A). In con-
trast, occupancy at the −10 kb enhancer showed relatively
unchanged levels for MED1, whereas Brg1 occupancy in-
creased as a function of adipogenesis with similar kinetics
to Prmt5 (Figure 4B).
Prmt5 is required for MED1 and Brg1 binding at the
PPAR2 locus
We initiated experiments to understand the relationship
between the binding of Prmt5, Brg1 and MED1 at the
PPAR2 locus. Two independent siRNAs for Prmt5 were
tested and validated for a block of adipogenesis by Oil Red
O staining (Figure 5A–C) as well as reduction in Prmt5 pro-
tein level (Figure 5D). Surprisingly, MED1 was recruited in
a Prmt5 dependent manner, as Prmt5 depletion prevented
MED1 binding at both the promoter and upstream en-
hancer of PPAR2 (Figure 5E). Binding of Brg1 to the pro-
moter and enhancer was also greatly impaired at each time
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Figure 5. Knockdown of Prmt5 blocked binding of Brg1 and MED1 to the PPAR2 locus. C3H10T1/2 cells were treated with one of two independent
siRNAs for Prmt5 or a scrambled sequence control. (A–C) Oil Red O staining of cells treated with scrambled, Prmt5 siRNA Oligo 3 or Prmt5 siRNA
oligo 5. (D) Western demonstrating Prmt5 knockdown. (E–G) Chromatin immunoprecipitation (ChIP) experiments were performed on C3H10T1/2 cells
differentiated for 0, 12 and 96 h. DNA was immunoprecipitated with antibodies against (E) MED1, (F) Brg1 or (G) Prmt5. Top panels indicate binding
at the PPAR2 promoter while bottom panels indicate binding at the −10 kb enhancer. Data are presented as fold enrichment over the amount of DNA
amplified after immunoprecipitation by the control IgG. Analysis of three independent samples were performed in triplicate. Error bars: Mean + SD (*P
< 0.05, **P < 0.01, ***P < 0.001 by Student’s t-test).
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Figure 6. Overexpression of Prmt5 results in earlier recruitment ofMED1
to the PPAR2 promoter. C3H10T1/2 cells were infected with retrovirus
containing either empty vector or Prmt5. ChIP experiments for MED1
were performed on cells differentiated for the indicated times. DNA im-
munoprecipitated by theMED1 antibody was amplified and quantified by
real-time PCR for the (A) PPAR2 promoter or (B) the −10 kb enhancer.
Data are presented as fold enrichment over the amount of DNA amplified
after immunoprecipitation by the control IgG. Experiments from three in-
dependent samples were performed in triplicate. Error bars: Mean + SD
(*P < 0.05, ***P < 0.001 by Student’s two tailed t-test).
point (Figure 5F), consistent with our previous observa-
tions that knockdown of Prmt5 blocks Brg1 binding at adi-
pogenic target promoters (18). As a control, knockdown of
Prmt5 ablated binding of Prmt5 to the upstream enhancer
at the 12 and 96 h time points, but showed no effect on pro-
moter binding (Figure 5G). Thus, Prmt5 is needed for the
occupancy of both Brg1 and MED1 at both the promoter
and upstream enhancer of PPAR2.
Overexpression of Prmt5 facilitates earlier recruitment of
MED1
Given our earlier findings that overexpression of Prmt5
led to more rapid differentiation (18) as well as premature
loop formation (Figure 2E), we tested whether the earlier
loop formation induced by overexpression of Prmt5 was
governed by recruitment of MED1. When overexpressing
Prmt5, we observed an earlier and greater occupancy for
MED1 at the PPAR2 promoter beginning at 3 h, with a
robust occupancy seen at 6 h (Figure 6A), which is coinci-
dent with the observed early loop formation at the PPAR2
promoter (Figure 2E). Enhanced Prmt5 occupancy was ob-
served at the promoter throughout adipogenesis (Figure
6A). At the enhancer where MED1 binding was constitu-
tive, a modest change was observed, most notably at the 6
h time point (Figure 6B). Thus, the earlier loop formation
caused by Prmt5 overexpression correlates with premature
enhanced binding of MED1.
MED1 is required for loop formation and for Brg1 and Prmt5
binding to the PPAR2 locus
Given our findings that Prmt5 was necessary for both
MED1 and Brg1 to bind, we tested whether the converse
was true. In order to address factors that are required for
loop formation, we examined the role of Mediator. Two in-
dependent siRNAs targetingMED1 blocked differentiation
in C3H10T1/2 cells (Figure 7A–C). Control western blots
validated the knockdown ofMED1 (Figure 7D). 3C studies
showed that MED1 knockdown also reduced loop forma-
tion at the 12 and 96 h time points (Figure 7E). These results
show a necessary role forMED1 in both differentiation and
loop formation. Having shown that loss of Prmt5 results in
a loss of MED1 and Brg1 to the PPAR2 promoter and
enhancer, we tested whether MED1 knockdown would in-
fluence the binding of Brg1 or Prmt5. Depletion of MED1
blocked binding ofMED1 (Figure 8A), of Brg1 (Figure 8B)
and of Prmt5 (Figure 8C). Thus, both MED1 and Prmt5
show a mutual requirement for each other in binding to the
PPAR2 locus.
Prmt5 and MED1 co-localize at PPAR2 regulatory se-
quences
The mutual dependence of Prmt5 and MED1 binding sug-
gests but does not prove that both factors are bound to-
gether on the same regulatory sequences at the same time.
To address this concern, we performed re-ChIP, also called
sequential ChIP, experiments. ChIP was performed on cells
differentiated for 6 or 96 h with MED1 antibody, and the
recovered DNA was prepared for a second ChIP using ei-
ther Prmt5 antibody or IgG as a control. The reciprocal
experiment was also performed. Amplification of DNA re-
covered from the second ChIP experiments identified the
PPAR2 promoter sequence at 6 h and to a lesser extent, at
96 h post-differentiation (Figure 9A and B, top panels), in
agreement with the enhanced binding of Prmt5 to the pro-
moter at 6 h (Figure 3A). Amplification of DNA recovered
from the second ChIP experiments identified the PPAR2
enhancer sequence at 96 h post-differentiation (Figure 9A
and B, bottom panels). Lower or negligible levels of en-
hancer sequence were recovered at the 6 h timepoint, as
expected based on the enhanced binding of Prmt5 to the
PPAR2 enhancer at the endpoint of differentiation (Fig-
ure 3A). The results indicate co-localization of Prmt5 and
MED1 on PPAR2 regulatory sequences.
Prmt5 is required for other higher-order chromatin interac-
tions in differentiating adipocytes
We next determined whether Prmt5 is involved in other
higher-order chromatin interactions that occur in differen-
tiating adipocytes. The uncoupling proteins Ucp2 and 3 are
likely involved in mitochondrial function (45–47) but may
also play a role in limiting reactive oxygen species forma-
tion during respiration (48–50). The genes encoding Ucp2
and Ucp3 are next to each other on mouse chromosome 7
and are separated by∼20 kb. Bugge et al. previously showed
that an intronic enhancer in the Ucp3 gene loops to con-
tact the promoter of the Ucp2 gene in 3T3-L1 cells (32). We
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Figure 7. MED1 knockdown prevents formation of the loop between the PPAR2 −10 kb enhancer and the promoter. C3H10T1/2 cells were treated
with scrambled or one of two independent siRNA oligos. (A–C) Oil Red O staining showing inhibition of adipogenesis by siRNA for MED1. (D) Western
blot showing MED1 knockdown. (E) Samples were harvested at the 0, 12 and 96 h time points for a 3C assay. Interaction frequency at the 0 h timepoint
for the scrambled control was set at 0 and other values are presented relative to that value. Experiments from three independent samples were performed
in triplicate. Error bars: Mean + SD (***P < 0.001 by Student’s two tailed t-test).
performed 3C experiments over a time course of 3T3-L1 dif-
ferentiation and identified the existence of the loop at day
4 of the differentiation process (Supplemental Figure S4A),
consistent with the published study. The same experiment
performed in differentiating C3H10T1/2 cells yielded sim-
ilar results, with the only difference being a slightly earlier
onset of loop formation (Figure 10A). A reduction in Prmt5
levels caused a significantly lower interaction frequency be-
tween the Ucp2 and 3 loci in both the C3H10T1/2 (Fig-
ure 10B) and the 3T3-L1 cell backgrounds (Supplemental
Figure S4B). Ucp2 and 3 are both induced by PPAR (32),
andwe have previously shown that knockdownof Prmt5 de-
creases PPAR2 and PPAR2 target gene expression while
overexpression of Prmt5 increases PPAR2 expression (18).
As expected, Ucp2 and Ucp3 mRNA levels were reduced
in cells knocked down for Prmt5 in both C3H10T1/2 and
3T3-L1 cells (Figure 10C and Supplemental Figure S4C).
In other previously published work, we determined that
the PPAR2 promoter makes long-range, transient, con-
tacts with the promoters of several different PPAR tar-
get genes in both 3T3-L1 and C3H10T1/2 cells (23). We
examined whether reduction of Prmt5 affected the in-
teraction frequencies between the PPAR2 promoter on
chromosome 6 and the AdipoQ or perilipin 2 (Plin2)
promoters on chromosomes 16 and 4, respectively. The
inter-chromosomal interactions were completely Prmt5-
dependent. (Figure 10D and E). The data indicate that
Prmt5 is not solely required for loop formation at the
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Figure 8. Knockdown of MED1 blocked binding of Brg1 and Prmt5 to the PPAR2 locus. C3H10T1/2 cells were treated with one of two independent
siRNAs for MED1 or a scrambled control siRNA. ChIP experiments were performed on cells differentiated for the indicated times. DNA immunoprecip-
itated by antibodies against (A) MED1, (B) Brg1 or (C) Prmt5 was amplified and quantified by real-time PCR for the PPAR2 promoter (top) and the
PPAR2 −10 kb enhancer (bottom). Data are presented as fold enrichment over the amount of DNA amplified after immunoprecipitation by the control
IgG. Experiments from three independent samples were performed in triplicate. Error bars: Mean + SD (*P< 0.05, **P< 0.01, ***P< 0.001 by Student’s
two tailed t-test).
Figure 9. MED1 and Prmt5 are co-localized on the same regulatory sequences. Re-ChIP experiments were performed on C3H10T1/2 cells differentiated
for 6 or 96 h. (A) Experiments analyzing binding to PPAR2 promoter or enhancer sequences using a MED1 antibody followed by either IgG or a Prmt5
antibody for the second ChIP. (B) Experiments analyzing binding to PPAP2 promoter or enhancer sequences using a Prmt5 antibody followed by either
IgG or a MED1 antibody for the second ChIP. Results are shown as % input rather than relative enhancement to allow better presentation of the IgG
control. Experiments from three independent samples were performed in triplicate. Error bars: Mean + SD (*P < 0.05 by Student’s two tailed t-test).
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Figure 10. Prmt5 mediates the formation of other DNA loops and inter-chromosomal interactions during adipogenic differentiation. (A) Time course of
relative interaction frequency between the Ucp2 and Ucp3 loci. Samples of C3H10T1/2 cells were taken at the 0 h timepoint and at 3, 6, 12, 24 and 96 h
following differentiation. (B) Control vector and antisense Prmt5 expressing C3H10T1/2 cells either collected prior to differentiation (0 h) or 96 h later
were tested by 3C for interactions between the Ucp2 and Ucp3 loci. (C) Control vector and antisense Prmt5 expressing C3H10T1/2 cells either collected
prior to differentiation (0 h) or 96 h later were used to determine expression levels of Ucp3 and Ucp2, normalized to levels of GAPDH, by quantitative
PCR. Data are presented as fold induction relative to the expression at time 0, which was set to 1. (D and E) Interaction frequencies between the PPAR2
promoter and the promoters of the adiponectin (AdipoQ) or perilipin 2 (Plin2) genes in C3H10T1/2 cells treated with scramble sequence (scr) siRNA or
siRNAs targeting Prmt5 that were differentiated for the indicated times. All results are from three independent samples performed in triplicate. Error bars:
Mean + SD (*P < 0.05, **P < 0.01, ***P < 0.001 by Student’s two tailed t-test).
PPAR2 locus but also mediates other long-distance chro-
matin interactions both in cis and in trans during adipocyte
differentiation.
DISCUSSION
Genomic structure of the PPAR2 locus
Three putative enhancers for the PPAR2 gene have been
previously identified on the basis of chromatin signature
marks and binding by the adipogenic regulatory factors
C/EBP, C/EBP and PPAR2 (10). Two are located
downstream, at 97 and 101 kb relative to the start site of
transcription. The third is located ∼10 kb upstream of the
TSS; this sequence has been shown to drive transcription of
a reporter gene in 3T3-L1 pre-adipocytes induced to differ-
entiate (8). Here we demonstrate that this sequence mod-
estly activates a PPAR2 reporter driven by 1.6 kb of se-
quence upstream of the TSS and significantly drives re-
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porter gene expression in the presence of a C/EBP expres-
sion vector. When we performed 3C mapping of the 80 kb
upstream and the 80 kb downstream of the PPAR2 TSS
using proximal promoter sequences as the anchor, the −10
kb region was by far the most frequently interacting region
in differentiating cells. The simplest interpretation is that
a loop forms between the −10 kb enhancer sequence and
the proximal promoter, almost certainly for the purpose of
bringing the −10 kb region into close proximity to the pro-
moter and TSS. This is, to the best of our knowledge, the
first demonstration of a loop between regulatory elements
at the PPAR2 locus.
While we have focused on the differentiation-dependent
promoter–enhancer loop, we note that there were less fre-
quent, but still statistically significant interactions between
the PPAR2 promoter and sequences at ∼+10 kb relative
to the TSS and, to an even lesser extent, between the pro-
moter and sequences at −20 to −25 kb relative to the TSS.
Sequence analysis of these regions does not indicate tran-
scription factor hot spots, histonemarks or DNAse I hyper-
sensitivity that would be indicative of enhancer sequences.
The significance of these interactions, if any, remains to be
determined.We also note that the entire locus shows a com-
plex pattern of interactions prior to the onset of differenti-
ation signaling and that much of this ‘structure’ does not
change after the onset of differentiation. The PPAR2 pro-
moter is contained within intron 2 of the PPAR1 gene. It is
possible that much of the observed three-dimensional struc-
ture relates to higher order organization of the entire region
and that differentiation-dependent induction of PPAR2
gene expression results entirely from the formation of the
promoter–enhancer loop we have documented.
Kinetics of molecular changes at the PPAR2 locus during
adipogenic differentiation
Over the course of several studies, we have determined that
nuclease sensitivity at the PPAR2 promoter occurs within
minutes of adipogenic differentiation signaling, followed by
binding of c-fos. C/EBP binding occurs within an hour
of the onset of differentiation (51). We also determined
that the PPAR2 locus subsequently makes transient, long-
range intra-chromosomal as well as inter-chromosomal in-
teractions with adipokine and other PPAR2 target genes
and concluded that genome organization is dynamically re-
modeled in response to adipogenic signaling, perhaps for
the purpose of identifying transcriptionally silent tissue-
specific loci for subsequent transcriptional activation (23).
All of these events required protein kinase A signaling, and
elevated cyclic AMP (cAMP) levels were sufficient to in-
duce these events even though elevated cAMP does not sup-
port completion of the adipogenic differentiation process
(23,51). In the current study, we provide additional details
about the molecular changes that occur at the PPAR2 lo-
cus after the onset of differentiation and coincident with ex-
pression of the PPAR2 gene. Subsequent to the transient
interaction of the PPAR2 locus with several target gene
loci, a loop forms between the PPAR2 promoter and an
enhancer sequence 10 kb upstream of the TSS. We specu-
late that long-range alteration of relative adipogenic gene
positioning is part of the process by which tissue specific
loci are spatially organized in the nucleus and that this more
global genome organization necessarily precedes the locus-
specific structural rearrangement of relevant transcriptional
regulatory sequences that directly promote transcriptional
activation.
The roles of Prmt5 and MED1 in loop formation at the
PPAR2 locus
Prmt5 is a methyltransferase that symmetrically dimethy-
lates arginine residues on substrate molecules, which in-
clude histones, transcription and splicing factors, and many
other proteins (52,53). We previously determined that
Prmt5 is required for both myogenic and adipogenic dif-
ferentiation via mechanisms that involved binding to tar-
get genes and facilitating the recruitment of the mammalian
SWI/SNF chromatin remodeling enzyme (16–18), which
is required for activation of differentiation-specific genes
(34,54–57). In our previous report, we showed that Prmt5
was bound to the−10 kb enhancer at the end point of differ-
entiation, but could not be captured by ChIP assay on the
promoter at the same time (18). In the current study, kinetic
analysis of Prmt5 binding indicates that Prmt5 initiates in-
teractionwith the PPAR2 gene at promoter sequences, but
this interaction is transient and cannot be seen by the time
loop formation is first observed. In contrast, Prmt5 binding
to the enhancer sequence gradually increases throughout
the time course of differentiation and remains present after
loop formation.Why binding kinetics differ as the promoter
and enhancer is unclear. Prmt5 is not known to have any
sequence-specific DNA binding activity and is presumed
to bind via interaction with transcription factors. Perhaps
Prmt5 binding to the promoter persists but steric consider-
ations caused by loop formation prevent cross-linking be-
tween Prmt5 and the promoter sequences. Alternatively,
perhaps the nucleosome structure of the PPAR2 promoter
is organized in such a manner that Prmt5 interaction at
the promoter leads to subsequent reorganization of chro-
matin structure at the enhancer. Such a model would be
consistent with DNAse I hypersensitivity studies indicat-
ing that increased nuclease sensitivity at the PPAR2 pro-
moter precedes increased nuclease sensitivity at the −10
kb enhancer (9). Another possibility is that Prmt5 bind-
ing at different times and locations indicate separable func-
tions. Prmt5 binding at the promoter correlates with the
timing of the inter- and long-range intra-chromosomal in-
teractions between the PPAR2 promoter and other adi-
pogenic loci (23). Since Prmt5 binding promotes interac-
tion of SWI/SNF chromatin remodeling enzymes with the
chromatin (16–18) and it has been documented that the
Brg1 ATPase of mammalian SWI/SNF chromatin remod-
eling enzymes mediates both locus-specific chromatin re-
organization (35,37,39,40) as well as formation of inter-
chromosomal interactions in other differentiation systems
(58), perhaps binding of Prmt5, and, by extension, target-
ing SWI/SNF enzyme to the promoter, is part of themecha-
nism bywhich the inter- and long-range intra-chromosomal
interactions between the PPAR2 locus and target gene loci
are facilitated.
The connection between Prmt5 and loop formation es-
tablished by our kinetic analyses of Prmt5 binding, loop for-
 at U
niversity of M
assachusetts M
edical School on July 6, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2016, Vol. 44, No. 11 5145
mation and PPAR2 expression is solidified by our demon-
stration that Prmt5 knockdown prevents all three of these
events and that Prmt5 overexpression causes premature
loop formation and early expression of PPAR2. Further
investigation centered on Mediator complex, which is a
large, multi-subunit cofactor of RNA polymerase II that
facilitates activator-mediated transcription (41,59). Media-
tor subunits were long ago recognized as essential molec-
ular components of the adipogenic gene expression and
differentiation processes (42,60,61), and Mediator, in con-
junction with cohesion, were determined to physically con-
nect enhancers and promoters (62). More recently, detailed
analyses of the three-dimensional structural organization of
multiple loci in ES cells programmed to differentiate along
the neuro-ectodermal lineage showed that a Mediator–
cohesin complex bridges short-range enhancer–promoter
connections and that knockdown ofMediator subunits dis-
rupted the spatial architecture of the examined loci (63).
We determined that Mediator interacts constitutively with
the PPAR2 upstream enhancer and inducibly at the pro-
moter, matching the kinetics of Prmt5 promoter binding. A
schematic model of the molecular changes that occur at the
PPAR2 promoter is presented in Supplemental Figure S5.
Consistent with expectations based on the literature,
knockdown of Mediator subunit MED1 inhibited differ-
entiation and greatly reduced loop formation. Perhaps not
surprisingly, MED1 knockdown also prevented Prmt5 and
SWI/SNF enzyme binding. It is known that both Brg1 and
Prmt5 interact with theCDKproteins of theMediator com-
plex in other biological contexts (44,64). Additionally, the
loss of the CDK proteins in Mediator prevented interac-
tion with Prmt5 and loss of Prmt5 binding at C/EBP tar-
get genes during immune responses, suggesting interplay be-
tween the factors (44). Thus the observation of loss of Prmt5
and Brg1 binding upon MED1 knockdown supports and
extends the previous findings.
What was unexpected was the observation that MED1
and Prmt5 show mutual dependency for binding to the
PPAR2, as Prmt5 knockdown significantly reducedMedi-
ator binding. This observation suggests that Mediator and
Prmt5may be recruited while as part of a complex in aman-
ner that requires the integrity of both components. Simi-
larly, the integrity of both components presumably would
then be required for promoter–enhancer loop formation at
the PPAR2 locus. The exact nature of the mutual depen-
dency between Prmt5 and Mediator remains to be deter-
mined, but the links between the two presented here and in
other biological systems suggest that combined functional-
ity is a general occurrence.
Pleiotropic Prmt5 functions
Here we report that Prmt5 facilitates promoter–enhancer
looping and gene expression at the PPAR2 locus, which
encodes a critical lineage-determining factor that drives
the differentiation of adipose tissue. In addition, we report
that Prmt5 mediates long-range, inter-chromosomal inter-
actions involving the PPAR locus as well as looping in-
teractions between gene loci expressed during adipogene-
sis. These data suggest that Prmt5 may be broadly required
for the formation of higher-order chromatin interactions
during adipocyte differentiation, although the global extent
of this Prmt5 requirement remains to be determined. This
novel Prmt5 function adds organization of higher-order
chromatin structure to a long list of properties attributed to
Prmt5. Prmt5 is essential for early embryonic viability and
epiblast differentiation (12),marking it as an essential devel-
opmental regulator. It is found in both the nucleus and cy-
toplasm (65) and has been implicated in not just transcrip-
tional regulation and control of chromatin modification but
also in signal transduction, both at the cell membrane as
well as in the cytosol, splicing, glucose metabolism and the
DNA damage response (66–71). Prmt5 itself has associated
cofactors with which it interacts, including Mep50, which
is required for many Prmt5 functions (72,73), Rio Kinase
1 and ICLN, which antagonistically regulate Prmt5 sub-
strate specificity in the cytoplasm and may implicate Prmt5
in rRNAprocessing (74,75), COPR5, which regulates speci-
ficity of histonemethylation and can promote the transition
between precursor cell and differentiation (68,75,76), and
HSP90, which promotes protein stability (77). All of these
functions likely impact the progression of a differentiation
pathway. The ever-growing data indicate that Prmt5 plays a
significant role in multiple molecular events governing de-
velopment, cell proliferation and metabolism, genome or-
ganization, and gene expression, thereby implicating it as a
general regulator of cellular function.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENT
We thank AR Barutcu and H Xiao for technical assistance
and advice.
FUNDING
National Institutes of Health (NIH) [DK084278 to S.S.,
A.N.I., GM56244 to A.N.I., F32DK082263 to S.E.L.,
DK32520 to UMass Medical School Diabetes and En-
docrine Research Center]. Funding for open access charge:
Institutional funds.
Conflict of interest statement.None declared.
REFERENCES
1. Rosen,E.D. and MacDougald,O.A. (2006) Adipocyte differentiation
from the inside out. Nat. Rev. Mol. Cell. Biol., 7, 885–896.
2. Farmer,S.R. (2006) Transcriptional control of adipocyte formation.
Cell Metab., 4, 263–273.
3. Siersbaek,R., Baek,S., Rabiee,A., Nielsen,R., Traynor,S., Clark,N.,
Sandelin,A., Jensen,O.N., Sung,M.H., Hager,G.L. et al. (2014)
Molecular architecture of transcription factor hotspots in early
adipogenesis. Cell Rep., 7, 1434–1442.
4. Siersbæk,R., Baek,S., Rabiee,A., Nielsen,R., Traynor,S., Clark,N.,
Sandelin,A., Jensen,O.N., Sung,M.-H., Hager,G.L. et al. (2014)
Molecular architecture of transcription factor hotspots in early
adipogenesis. Cell Rep., 7, 1434–1442.
5. Lefterova,M.I. and Lazar,M.A. (2009) New developments in
adipogenesis. Trends Endocrinol. Metab., 20, 107–114.
6. Lefterova,M.I., Zhang,Y., Steger,D.J., Schupp,M., Schug,J.,
Cristancho,A., Feng,D., Zhuo,D., Stoeckert Jr,C.J., Liu,X.S. et al.
(2008) PPARgamma and C/EBP factors orchestrate adipocyte
 at U
niversity of M
assachusetts M
edical School on July 6, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
5146 Nucleic Acids Research, 2016, Vol. 44, No. 11
biology via adjacent binding on a genome-wide scale. Genes Dev., 22,
2941–2952.
7. Nolis,I.K., McKay,D.J., Mantouvalou,E., Lomvardas,S., Merika,M.
and Thanos,D. (2009) Transcription factors mediate long-range
enhancer-promoter interactions. Proc. Natl. Acad. Sci. U.S.A., 106,
20222–20227.
8. Steger,D.J., Grant,G.R., Schupp,M., Tomaru,T., Lefterova,M.I.,
Schug,J., Manduchi,E., Stoeckert,C.J. and Lazar,M.A. (2010)
Propagation of adipogenic signals through an epigenomic transition
state. Genes Dev., 24, 1035–1044.
9. Siersbaek,R., Nielsen,R., John,S., Sung,M.H., Baek,S., Loft,A.,
Hager,G.L. and Mandrup,S. (2011) Extensive chromatin remodelling
and establishment of transcription factor ‘hotspots’ during early
adipogenesis. EMBO J., 30, 1459–1472.
10. Lee,J.-E., Wang,C., Xu,S., Cho,Y.-W., Wang,L., Feng,X.,
Baldridge,A., Sartorelli,V., Zhuang,L., Peng,W. et al. (2013) H3K4
mono- and di-methyltransferase MLL4 is required for enhancer
activation during cell differentiation. Elife, 2, e01503.
11. Siersbaek,R., Rabiee,A., Nielsen,R., Sidoli,S., Traynor,S., Loft,A.,
La Cour Poulsen,L., Rogowska-Wrzesinska,A., Jensen,O.N. and
Mandrup,S. (2014) Transcription factor cooperativity in early
adipogenic hotspots and super-enhancers. Cell Rep., 7, 1443–1455.
12. Tee,W.W., Pardo,M., Theunissen,T.W., Yu,L., Choudhary,J.S.,
Hajkova,P. and Surani,M.A. (2010) Prmt5 is essential for early mouse
development and acts in the cytoplasm to maintain ES cell
pluripotency. Genes Dev., 24, 2772–2777.
13. Fabbrizio,E., El Messaoudi,S., Polanowska,J., Paul,C., Cook,J.R.,
Lee,J.H., Negre,V., Rousset,M., Pestka,S., Le Cam,A. et al. (2002)
Negative regulation of transcription by the type II arginine
methyltransferase PRMT5. EMBO Rep., 3, 641–645.
14. Pal,S., Vishwanath,S.N., Erdjument-Bromage,H., Tempst,P. and
Sif,S. (2004) Human SWI/SNF-associated PRMT5 methylates
histone H3 arginine 8 and negatively regulates expression of ST7 and
NM23 tumor suppressor genes.Mol. Cell. Biol., 24, 9630–9645.
15. Wei,H., Mundade,R., Lange,K.C. and Lu,T. (2014) Protein arginine
methylation of non-histone proteins and its role in diseases. Cell
Cycle, 13, 32–41.
16. Dacwag,C.S., Bedford,M.T., Sif,S. and Imbalzano,A.N. (2009)
Distinct protein arginine methyltransferases promote ATP-dependent
chromatin remodeling function at different stages of skeletal muscle
differentiation.Mol. Cell. Biol., 29, 1909–1921.
17. Dacwag,C.S., Ohkawa,Y., Pal,S., Sif,S. and Imbalzano,A.N. (2007)
The protein arginine methyltransferase Prmt5 is required for
myogenesis because it facilitates ATP-dependent chromatin
remodeling.Mol. Cell. Biol., 27, 384–394.
18. LeBlanc,S.E., Konda,S., Wu,Q., Hu,Y.-J., Oslowski,C.M., Sif,S. and
Imbalzano,A.N. (2012) Protein arginine methyltransferase 5 (Prmt5)
promotes gene expression of peroxisome proliferator-activated
receptor 2 (PPAR2) and its target genes during adipogenesis.Mol.
Endocrinol., 26, 583–597.
19. Dekker,J., Rippe,K., Dekker,M. and Kleckner,N. (2002) Capturing
chromosome conformation. Science, 295, 1306–1311.
20. Osborne,C.S., Chakalova,L., Brown,K.E., Carter,D., Horton,A.,
Debrand,E., Goyenechea,B., Mitchell,J.A., Lopes,S., Reik,W. et al.
(2004) Active genes dynamically colocalize to shared sites of ongoing
transcription. Nat. Genet., 36, 1065–1071.
21. Sexton,T., Kurukuti,S., Mitchell,J.A., Umlauf,D., Nagano,T. and
Fraser,P. (2012) Sensitive detection of chromatin coassociations using
enhanced chromosome conformation capture on chip. Nat. Potoc., 7,
1335–1350.
22. Palstra,R.J., Tolhuis,B., Splinter,E., Nijmeijer,R., Grosveld,F. and de
Laat,W. (2003) The beta-globin nuclear compartment in development
and erythroid differentiation. Nat. Genet., 35, 190–194.
23. LeBlanc,S.E., Wu,Q., Barutcu,A.R., Xiao,H., Ohkawa,Y. and
Imbalzano,A.N. (2014) The PPAR locus makes long-range
chromatin interactions with selected tissue-specific gene loci during
adipocyte differentiation in a protein kinase A dependent manner.
PLoS One, 9, e86140.
24. Pal,S., Yun,R., Datta,A., Lacomis,L., Erdjument-Bromage,H.,
Kumar,J., Tempst,P. and Sif,S. (2003) mSin3A/histone deacetylase 2-
and PRMT5-containing Brg1 complex is involved in transcriptional
repression of the Myc target gene cad.Mol. Cell. Biol., 23, 7475–7487.
25. Pear,W.S., Nolan,G.P., Scott,M.L. and Baltimore,D. (1993)
Production of high-titer helper-free retroviruses by transient
transfection. Proc. Natl. Acad. Sci. U.S.A., 90, 8392–8396.
26. Schmittgen,T.D. and Livak,K.J. (2008) Analyzing real-time PCR data
by the comparative C(T) method. Nat. Protoc., 3, 1101–1108.
27. de La Serna,I.L., Carlson,K.A., Hill,D.A., Guidi,C.J.,
Stephenson,R.O., Sif,S., Kingston,R.E. and Imbalzano,A.N. (2000)
Mammalian SWI-SNF complexes contribute to activation of the
hsp70 gene.Mol. Cell. Biol., 20, 2839–2851.
28. Gill,G. and Ptashne,M. (1988) Negative effect of the transcriptional
activator GAL4. Nature, 334, 721–724.
29. Bartkuhn,M. and Renkawitz,R. (2008) Long range chromatin
interactions involved in gene regulation. Biochim. Biophys. Acta,
1783, 2161–2166.
30. Harms,M.J., Lim,H.-W., Ho,Y., Shapira,S.N., Ishibashi,J.,
Rajakumari,S., Steger,D.J., Lazar,M.A., Won,K.-J. and Seale,P.
(2015) PRDM16 binds MED1 and controls chromatin architecture to
determine a brown fat transcriptional program. Genes Dev., 29,
298–307.
31. Iida,S., Chen,W., Nakadai,T., Ohkuma,Y. and Roeder,R.G. (2015)
PRDM16 enhances nuclear receptor-dependent transcription of the
brown fat-specific Ucp1 gene through interactions with Mediator
subunit MED1. Genes Dev., 29, 308–321.
32. Bugge,A., Siersbaek,M., Madsen,M.S., Gondor,A., Rougier,C. and
Mandrup,S. (2010) A novel intronic peroxisome
proliferator-activated receptor gamma enhancer in the uncoupling
protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression
in adipocytes. J. Biol. Chem., 285, 17310–17317.
33. Dekker,J. (2006) The three ‘C’ s of chromosome conformation
capture: controls, controls, controls. Nat. Methods, 3, 17–21.
34. Salma,N., Xiao,H., Mueller,E. and Imbalzano,A.N. (2004) Temporal
recruitment of transcription factors and SWI/SNF
chromatin-remodeling enzymes during adipogenic induction of the
peroxisome proliferator-activated receptor gamma nuclear hormone
receptor.Mol. Cell. Biol., 24, 4651–4663.
35. Kim,S.I., Bresnick,E.H. and Bultman,S.J. (2009) BRG1 directly
regulates nucleosome structure and chromatin looping of the alpha
globin locus to activate transcription. Nucleic Acids Res., 37,
6019–6027.
36. Kim,S.I., Bultman,S.J., Jing,H., Blobel,G.A. and Bresnick,E.H.
(2007) Dissecting molecular steps in chromatin domain activation
during hematopoietic differentiation.Mol. Cell. Biol., 27, 4551–4565.
37. Kim,S.I., Bultman,S.J., Kiefer,C.M., Dean,A. and Bresnick,E.H.
(2009) BRG1 requirement for long-range interaction of a locus
control region with a downstream promoter. Proc. Natl. Acad. Sci.
U.S.A., 106, 2259–2264.
38. Bossen,C., Murre,C.S., Chang,A.N., Mansson,R., Rodewald,H.R.
and Murre,C. (2015) The chromatin remodeler Brg1 activates
enhancer repertoires to establish B cell identity and modulate cell
growth. Nat. Immunol., 16, 775–784.
39. Cai,S., Lee,C.C. and Kohwi-Shigematsu,T. (2006) SATB1 packages
densely looped, transcriptionally active chromatin for coordinated
expression of cytokine genes. Nat. Genet., 38, 1278–1288.
40. Ni,Z., Abou El Hassan,M., Xu,Z., Yu,T. and Bremner,R. (2008) The
chromatin-remodeling enzyme BRG1 coordinates CIITA induction
through many interdependent distal enhancers. Nat. Immunol., 9,
785–793.
41. Allen,B.L. and Taatjes,D.J. (2015) The mediator complex: a central
integrator of transcription. Nat. Rev. Mol. Cell. Biol., 16, 155–166.
42. Ge,K., Guermah,M., Yuan,C.-X., Ito,M., Wallberg,A.E.,
Spiegelman,B.M. and Roeder,R.G. (2002) Transcription coactivator
TRAP220 is required for PPAR gamma 2-stimulated adipogenesis.
Nature, 417, 563–567.
43. Carlsten,J.O., Zhu,X. and Gustafsson,C.M. (2013) The multitalented
Mediator complex. Trends Biochem. Sci., 38, 531–537.
44. Tsutsui,T., Fukasawa,R., Shinmyouzu,K., Nakagawa,R., Tobe,K.,
Tanaka,A. and Ohkuma,Y. (2013) Mediator complex recruits
epigenetic regulators via its two cyclin-dependent kinase subunits to
repress transcription of immune response genes. J. Biol. Chem., 288,
20955–20965.
45. Fleury,C., Neverova,M., Collins,S., Raimbault,S., Champigny,O.,
Levi-Meyrueis,C., Bouillaud,F., Seldin,M.F., Surwit,R.S.,
Ricquier,D. et al. (1997) Uncoupling protein-2: a novel gene linked to
obesity and hyperinsulinemia. Nat. Genet., 15, 269–272.
 at U
niversity of M
assachusetts M
edical School on July 6, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2016, Vol. 44, No. 11 5147
46. Gong,D.W., He,Y., Karas,M. and Reitman,M. (1997) Uncoupling
protein-3 is a mediator of thermogenesis regulated by thyroid
hormone, beta3-adrenergic agonists, and leptin. J. Biol. Chem., 272,
24129–24132.
47. Jaburek,M., Varecha,M., Gimeno,R.E., Dembski,M., Jezek,P.,
Zhang,M., Burn,P., Tartaglia,L.A. and Garlid,K.D. (1999) Transport
function and regulation of mitochondrial uncoupling proteins 2 and
3. J. Biol. Chem., 274, 26003–26007.
48. Arsenijevic,D., Onuma,H., Pecqueur,C., Raimbault,S.,
Manning,B.S., Miroux,B., Couplan,E., Alves-Guerra,M.C.,
Goubern,M., Surwit,R. et al. (2000) Disruption of the uncoupling
protein-2 gene in mice reveals a role in immunity and reactive oxygen
species production. Nat. Genet., 26, 435–439.
49. Bouillaud,F. (2009) UCP2, not a physiologically relevant uncoupler
but a glucose sparing switch impacting ROS production and glucose
sensing. Biochim. Biophys. Acta, 1787, 377–383.
50. Pi,J., Bai,Y., Daniel,K.W., Liu,D., Lyght,O., Edelstein,D.,
Brownlee,M., Corkey,B.E. and Collins,S. (2009) Persistent oxidative
stress due to absence of uncoupling protein 2 associated with impaired
pancreatic beta-cell function. Endocrinology, 150, 3040–3048.
51. Xiao,H., Leblanc,S.E., Wu,Q., Konda,S., Salma,N., Marfella,C.G.A.,
Ohkawa,Y. and Imbalzano,A.N. (2011) Chromatin accessibility and
transcription factor binding at the PPAR2 promoter during
adipogenesis is protein kinase A-dependent. J. Cell. Physiol., 226,
86–93.
52. Di Lorenzo,A. and Bedford,M.T. (2011) Histone arginine
methylation. FEBS Lett., 585, 2024–2031.
53. Yang,Y. and Bedford,M.T. (2013) Protein arginine methyltransferases
and cancer. Nat. Rev. Cancer, 13, 37–50.
54. de la Serna,I.L., Carlson,K.A. and Imbalzano,A.N. (2001)
Mammalian SWI/SNF complexes promote MyoD-mediated muscle
differentiation. Nat. Genet., 27, 187–190.
55. de la Serna,I.L., Ohkawa,Y., Berkes,C.A., Bergstrom,D.A.,
Dacwag,C.S., Tapscott,S.J. and Imbalzano,A.N. (2005) MyoD targets
chromatin remodeling complexes to the myogenin locus prior to
forming a stable DNA-bound complex.Mol. Cell. Biol., 25,
3997–4009.
56. de la Serna,I.L., Ohkawa,Y., Higashi,C., Dutta,C., Osias,J.,
Kommajosyula,N., Tachibana,T. and Imbalzano,A.N. (2006) The
microphthalmia-associated transcription factor (MITF) requires
SWI/SNF enzymes to activate melanocyte specific genes. J. Biol.
Chem., 281, 20233–20241.
57. Pedersen,T.A., Kowenz-Leutz,E., Leutz,A. and Nerlov,C. (2001)
Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF
recruiting domains is required for adipocyte differentiation. Genes
Dev., 15, 3208–3216.
58. Harada,A., Mallappa,C., Okada,S., Butler,J.T., Baker,S.P.,
Lawrence,J.B., Ohkawa,Y. and Imbalzano,A.N. (2015) Spatial
re-organization of myogenic regulatory sequences temporally controls
gene expression. Nucleic Acids Res., 43, 2008–2021.
59. Poss,Z.C., Ebmeier,C.C. and Taatjes,D.J. (2013) The Mediator
complex and transcription regulation. Crit. Rev. Biochem. Mol. Biol.,
48, 575–608.
60. Ge,K., Cho,Y.W., Guo,H., Hong,T.B., Guermah,M., Ito,M., Yu,H.,
Kalkum,M. and Roeder,R.G. (2008) Alternative mechanisms by
which mediator subunit MED1/TRAP220 regulates peroxisome
proliferator-activated receptor gamma-stimulated adipogenesis and
target gene expression.Mol. Cell. Biol., 28, 1081–1091.
61. Yang,W., Rachez,C. and Freedman,L.P. (2000) Discrete roles for
peroxisome proliferator-activated receptor gamma and retinoid X
receptor in recruiting nuclear receptor coactivators.Mol. Cell. Biol.,
20, 8008–8017.
62. Kagey,M.H., Newman,J.J., Bilodeau,S., Zhan,Y., Orlando,D.A., van
Berkum,N.L., Ebmeier,C.C., Goossens,J., Rahl,P.B., Levine,S.S. et al.
(2010) Mediator and cohesin connect gene expression and chromatin
architecture. Nature, 467, 430–435.
63. Phillips-Cremins,J.E., Sauria,M.E., Sanyal,A., Gerasimova,T.I.,
Lajoie,B.R., Bell,J.S., Ong,C.T., Hookway,T.A., Guo,C., Sun,Y. et al.
(2013) Architectural protein subclasses shape 3D organization of
genomes during lineage commitment. Cell, 153, 1281–1295.
64. Fukasawa,R., Tsutsui,T., Hirose,Y., Tanaka,A. and Ohkuma,Y.
(2012) Mediator CDK subunits are platforms for interactions with
various chromatin regulatory complexes. J. Biochem., 152, 241–249.
65. Gu,Z., Li,Y., Lee,P., Liu,T., Wan,C. and Wang,Z. (2012) Protein
arginine methyltransferase 5 functions in opposite ways in the
cytoplasm and nucleus of prostate cancer cells. PLoS One, 7, e44033.
66. Jansson,M., Durant,S.T., Cho,E.C., Sheahan,S., Edelmann,M.,
Kessler,B. and Thangue,N.B. (2008) Arginine methylation regulates
the p53 response. Nat. Cell Biol., 10, 1431–1439.
67. Kanamaluru,D., Xiao,Z., Fang,S., Choi,S.E., Kim,D.H.,
Veenstra,T.D. and Kemper,J.K. (2011) Arginine methylation by
PRMT5 at a naturally occurring mutation site is critical for liver
metabolic regulation by small heterodimer partner.Mol. Cell. Biol.,
31, 1540–1550.
68. Paul,C., Sardet,C. and Fabbrizio,E. (2015) The Wnt-target gene
Dlk-1 is regulated by the Prmt5-associated factor Copr5 during
adipogenic conversion. Biol. Open, 4, 312–316.
69. Pesiridis,G.S., Diamond,E. and Duyne,G.D. (2009) Role of pICLn in
methylation of Sm proteins by PRMT5. J. Biol. Chem., 284,
21347–21359.
70. Sun,L., Wang,M., Lv,Z., Yang,N., Liu,Y., Bao,S., Gong,W. and
Xu,R.M. (2011) Structural insights into protein arginine symmetric
dimethylation by PRMT5. Proc. Natl. Acad. Sci. U.S.A., 108,
20538–20543.
71. Tsai,W.-W., Niessen,S., Goebel,N., Yates,J.R., Guccione,E. and
Montminy,M. (2013) PRMT5 modulates the metabolic response to
fasting signals. Proc. Natl. Acad. Sci. U.S.A., 110, 8870–8875.
72. Aggarwal,P., Vaites,L.P., Kim,J.K., Mellert,H., Gurung,B.,
Nakagawa,H., Herlyn,M., Hua,X., Rustgi,A.K., McMahon,S.B.
et al. (2010) Nuclear cyclin D1/CDK4 kinase regulates CUL4
expression and triggers neoplastic growth via activation of the
PRMT5 methyltransferase. Cancer Cell, 18, 329–340.
73. Friesen,W.J., Wyce,A., Paushkin,S., Abel,L., Rappsilber,J., Mann,M.
and Dreyfuss,G. (2002) A novel WD repeat protein component of the
methylosome binds Sm proteins. J. Biol. Chem., 277, 8243–8247.
74. Guderian,G., Peter,C., Wiesner,J., Sickmann,A., Schulze-Osthoff,K.,
Fischer,U. and Grimmler,M. (2011) RioK1, a new interactor of
protein arginine methyltransferase 5 (PRMT5), competes with pICln
for binding and modulates PRMT5 complex composition and
substrate specificity. J. Biol. Chem., 286, 1976–1986.
75. LaRonde-LeBlanc,N. and Wlodawer,A. (2005) A family portrait of
the RIO kinases. J. Biol. Chem., 280, 37297–37300.
76. Paul,C., Sardet,C. and Fabbrizio,E. (2012) The histone- and
PRMT5-associated protein COPR5 is required for myogenic
differentiation. Cell Death Differ., 19, 900–908.
77. Maloney,A., Clarke,P.A., Naaby-Hansen,S., Stein,R., Koopman,J.O.,
Akpan,A., Yang,A., Zvelebil,M., Cramer,R., Stimson,L. et al. (2007)
Gene and protein expression profiling of human ovarian cancer cells
treated with the heat shock protein 90 inhibitor
17-allylamino-17-demethoxygeldanamycin. Cancer Res., 67,
3239–3253.
 at U
niversity of M
assachusetts M
edical School on July 6, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
